Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Genetic targeting of microglia.
Neuroimaging-evident lesional pathology associated with REM sleep behavior disorder.
Ampyra for Optic Neuritis in MS
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation.
Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases.
Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.
Cognitive reserve and patient-reported outcomes in multiple sclerosis.
[Neuromyelitis optica: a case report].
The medicalisation of revolt: a sociological analysis of medical cannabis users.
Acute transverse myelitis following Japanese encephalitis viral infection: an uncommon complication of a common disease.
Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depression.
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data.
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.
New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS
GeNeuro Announces the Launch of Phase IIb Proof-of-Concept Study with GNbAC1 in Multiple Sclerosis and Servier Equity Investment
Reverse causality behind the association between reproductive history and MS.
Small molecule glutaminase inhibitors block glutamate release from stimulated microglia.
Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients.
Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination.
Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice.
Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints.
Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial.
Chronic social stress impairs virus specific adaptive immunity during acute Theiler's virus infection.
Acute Lymphoblastic Leukemia in a Man Treated With Fingolimod for Relapsing Multiple Sclerosis.
Pages
« first
‹ previous
…
265
266
267
268
269
270
271
272
273
…
next ›
last »